In the present study, we were able to verify these data regarding prognosis and VH gene mutation status, since our mutated CLL cases displayed more than twice as long median survival than the unmutated cases (138 vs 55 months).
In a recent whole-exome sequencing analysis of 99 pancreatic cancer specimens, the top 16 most frequently mutated genes were identified, including KRAS and TP53, but the FBW7 gene mutation status was not included.
K-ras gene mutations were not detected in any of the EGFR mutated tumours and this negative correlation was statistically significant (P=0.001), while EGFR gene mutation status did not correlate with p53 gene mutation status or with promoter hypermethylation status of p16, RASSF1A, or APC1A gene (Table 4).
Additionally, many people who do know they have such a mutation can now take preventive measures (such as Angelina Jolie's recent pre-emptive double mastectomy upon learning her BRCA gene mutation status), and we have no way of knowing whether they would have gone on to develop cancer if these measures had not been taken.
Molecular grade (mG) based on fibroblast growth factor receptor 3 (Fgene) gene mutation status and MIB-1 expression was proposed as an alternative to pathologic grade in bladder cancer (BCa) [1].
In this study, we have investigated the role of NF-kappaB in p53-dependent activation of Cox-2 in response to DNA damage, and we have analysed the correlations between TP53 gene mutation status and Cox-2 expression in esophageal ADC and SCC.
Several radiological features delineated by chest computed tomography (CT) of non-small cell lung cancer (NSCLC) have been reported to be associated with some utility in detecting the gene mutation status, such as epidermal growth factor receptor (EGFR) or anaplastic lymphoma kinase (ALK) rearrangement.
Thus, the IgVH gene mutation status correlated with TRF length.
K-Ras gene mutation status was assessed by direct sequencing.
The IGHV gene mutation status is one of the most reliable prognostic markers.
